JAMA Author Interviews podcast

Menopause-Associated Vasomotor Symptom Treatment With Elinzanetant

0:00
11:25
Rewind 15 seconds
Fast Forward 15 seconds

Nonhormonal treatments for menopausal vasomotor symptoms may benefit symptomatic patients who cannot take or prefer to avoid systemic hormones. Author JoAnn V. Pinkerton, MD, MSCP, discusses the efficacy and safety of elinzanetant for the treatment of moderate to severe vasomotor symptoms associated with menopause with JAMA Deputy Editor Linda Brubaker, MD, MS.

Related Content:

More episodes from "JAMA Author Interviews"